Angiotensin-converting enzyme 2: virus accomplice or host defender?

被引:0
作者
Wang Jiyan [1 ]
Chang Hongkai [1 ]
Qiao Yaya [1 ]
Sun Huanran [1 ]
Li Xichuan [6 ]
Yuan Shuofeng [10 ]
Zhang Shuai [17 ]
Shan Changliang [1 ]
机构
[1] State Key Laboratory of Emerging Infectious Diseases
[2] Carol Yu Centre for Infection  12. Department of Microbiology  13. Li Ka Shing Faculty of Medicine 
[3] School of Integrative Medicine
[4] Tianjin University of Traditional Chinese Medicine  19. Tianjin 301617
[5] State Key Laboratory of Medicinal Chemical Biology
[6] College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research  3. Nankai University  4. Tianjin 300350 
[7] Tianjin Key Laboratory of Animal and Plant Resistance
[8] College of Life Sciences  8. Tianjin Normal University  9. Tianjin 300387
关键词
ACE2; asymptomatic infection; COVID-19; metabolism; SARS-CoV-2;
D O I
暂无
中图分类号
R511 [病毒传染病];
学科分类号
100401 ;
摘要
Objective: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to social disruptions, mainly because we know too little about SARS-CoV-2.Methods and Results: In this study, we integrated RNA sequencing results and found that SARS-CoV-2 infection alters aerobic glycolysis, the oxidative pentose phosphate pathway (oxiPPP), and DNA replication in lung tissues and cells. However, the direction of metabolic flux and DNA replication are dominated by angiotensin-converting enzyme 2 (ACE2), a host cell-expressed viral receptor protein. More interestingly, although hosts with a high expression of ACE2 are more likely to be infected with SARS-CoV-2, the invading virus cannot perform nucleic acid replication well due to the restriction of glucose metabolism, eventually resulting in a prolonged infection cycle or infection failure.Conclusion: Our findings preliminarily explain the reasons for the emergence of asymptomatic infections at an early stage, which will provide assistance for the development of detection methods for diagnosing COVID-19.
引用
收藏
相关论文
共 50 条
  • [31] Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications
    Murray, Eleanor
    Tomaszewski, Maciej
    Guzik, Tomasz J.
    [J]. CARDIOVASCULAR RESEARCH, 2020, 116 (07) : E87 - E89
  • [32] Angiotensin-converting enzyme 2 and kidney diseases in the era of coronavirus disease 2019
    Suh, Sang Heon
    Ma, Seong Kwon
    Kim, Soo Wan
    Bae, Eun Hui
    [J]. KOREAN JOURNAL OF INTERNAL MEDICINE, 2021, 36 (02) : 247 - 262
  • [33] Nicotianamine is a novel angiotensin-converting enzyme 2 inhibitor in soybean
    Takahashi, Saori
    Yoshiya, Taku
    Yoshizawa-Kumagaye, Kumiko
    Sugiyama, Toshihiro
    [J]. BIOMEDICAL RESEARCH-TOKYO, 2015, 36 (03): : 219 - 224
  • [34] Angiotensin-converting enzyme-2: a molecular and cellular perspective
    Warner, FJ
    Smith, AI
    Hooper, NM
    Turner, AJ
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2004, 61 (21) : 2704 - 2713
  • [35] Angiotensin-converting enzyme 2 and new insights into the renin-angiotensin system
    Lambert, Daniel W.
    Hooper, Nigel M.
    Turner, Anthony J.
    [J]. BIOCHEMICAL PHARMACOLOGY, 2008, 75 (04) : 781 - 786
  • [36] Soluble angiotensin-converting enzyme 2 association with lipid metabolism
    Nagatomo, Izumi
    Nakanishi, Kaori
    Yamamoto, Ryohei
    Ide, Seiko
    Ishibashi, Chisaki
    Moriyama, Toshiki
    Yamauchi-Takihara, Keiko
    [J]. FRONTIERS IN MEDICINE, 2022, 9
  • [37] Cloning and characterization of a secreted form of angiotensin-converting enzyme 2
    Huentelman, MJ
    Zubcevic, J
    Katovich, MJ
    Raizada, MK
    [J]. REGULATORY PEPTIDES, 2004, 122 (02) : 61 - 67
  • [38] Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus
    Kuhn, JH
    Li, W
    Choe, H
    Farzan, M
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2004, 61 (21) : 2738 - 2743
  • [39] Angiotensin-converting enzyme 2 in human plasma and lung tissue
    Xie, Jing
    Huang, Qi-Fang
    Zhang, Zhihan
    Dong, Yihan
    Xu, Haimin
    Cao, Yanan
    Sheng, Chang-Sheng
    Li, Yan
    Wang, Chaofu
    Wang, Xuefeng
    Wang, Ji-Guang
    [J]. BLOOD PRESSURE, 2023, 32 (01) : 6 - 15
  • [40] Detection of soluble angiotensin-converting enzyme 2 in heart failure
    Epelman, Slava
    Tang, W. H. Wilson
    Chen, Stephen Y.
    Van Lente, Frederick
    Francis, Gary S.
    Sen, Subha
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (09) : 750 - 754